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A B S T R A C T
Helicobacter pylori (H. pylori) infection is considered a major risk factor for gastric cancer. CagA behaves
as a major bacterial oncoprotein playing a key role in H. pylori-induced tumorigenesis. Cancer stem cells
(CSCs) are believed to possess the ability to initiate tumorigenesis and promote progression. Although
studies have suggested that cancer cells can exhibit CSC-like properties in the tumor microenviron-
ment, it remains unclear whether H. pylori infection could induce the emergence of CSC-like properties
in gastric cancer cells and, the underlying mechanism. Here, gastric cancer cells were co-cultured with
a CagA-positive H. pylori strain or a CagA isogenic mutant strain. We found that H. pylori-infected gastric
cancer cells exhibited CSC-like properties, including an increased expression of CSC speciﬁc surfacemarkers
CD44 and Lgr5, as well as that of Nanog, Oct4 and c-myc, which are known pluripotency genes, and an
increased capacity for self-renewal, whereas these properties were not observed in the CagA isogenic
mutant strain-infected cells. Further studies revealed that H. pylori activated Wnt/β-catenin signaling
pathway in a CagA-dependent manner and that the activation of this pathway was dependent upon CagA-
positive H. pylori-mediated phosphorylation of β-catenin at the C-terminal Ser675 and Ser552 residues
in a c-met- and/or Akt-dependent manner. We further demonstrated that this activation was responsi-
ble for H. pylori-induced CSC-like properties. Moreover, we found the promoter activity of Nanog and
Oct4 were upregulated, and β-catenin was observed to bind to these promoters during H. pylori infec-
tion, while a Wnt/β-catenin inhibitor suppressed promoter activity and binding. Taken together, these
results suggest that H. pylori upregulates Nanog and Oct4 viaWnt/β-catenin signaling pathway to promote
CSC-like properties in gastric cancer cells.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Gastric cancer is a leading cause of cancer-related death world-
wide, and its incidence rates are highest in Eastern Asia, Central and
Eastern Europe, and South America. In 2012, an estimated 951,600
new gastric cancer cases and 723,100 deaths occurred [1].
Helicobacter pylori (H. pylori) infection is the strongest identiﬁed risk
factor for gastric cancer, and this bacterium has been classiﬁed as
a class 1 carcinogen by theWorld Health Organization. A recent study
has reported that approximately 89% of new cases of non-cardiac
gastric cancer can be attributed to H. pylori worldwide [2]. The
H. pylori genome shows genetic diversity among distinct isolates.
Thus, clinically isolated H. pylori strains are often subdivided into
two types according to the cag pathogenicity island (cag PAI)-
encoded cytotoxin-associated gene A (CagA) protein. Individuals
infected with CagA-positive H. pylori strains are at increased risk
of gastric cancer compared with those with CagA-negative H. pylori
infection [3,4]. In addition, it has been shown that CagA trans-
genic mice have a signiﬁcantly increased incidence of gastric cancer
[5,6]. The CagA protein, a major bacterial virulence factor that is in-
jected into gastric epithelial cells via the type IV secretion system
(T4SS), behaves as a bacterial oncoprotein [6]. Several different cag
PAI-encoded proteins function as the component of the T4SS, in-
cluding CagL, CagY, CagI and CagE, are involved in the translocation
of CagA [7–9]. Moreover, H. pylori can exploit host cell surface mol-
ecules such as integrins and phosphatidylserine to deliver CagA to
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the host cells in an energy-dependent manner [10]. Once it has
entered these target cells, it interacts with several host proteins, in-
cluding E-cadherin, GSK3β and tyrosine kinase c-met receptor
[11–13], and then continuously activates multiple oncogenic sig-
naling pathways, including the Wnt/β-catenin, PI3K/Akt, ERK/
MAPK, and JAK/STAT3 pathways [14]. Among these dysregulated
oncogenic signaling pathways, the aberrant Wnt/β-catenin signal-
ing pathway has attracted much attention and plays an essential
role in tumorigenesis, including gastric cancer.
The aberrant activatedWnt/β-catenin signaling pathway has been
implicated in contributing to tumorigenesis through the mainte-
nance of cancer stem cells (CSCs) [15]. CSCs have been deﬁned as
a subset of cancer cells that possess the ability to initiate tumori-
genesis. The theory of CSCs reasonably explains the heterogeneity
of cells within tumors, in which a subset of stem-like cells is able
to differentiate into all cell types [16]. To identify gastric CSCs, side
population analyses have been conducted, and different cell-
speciﬁc surface markers have been assessed. However, CD44 in
particular has been identiﬁed as a marker of gastric CSCs, and it is
still widely used at present [17].
β-catenin, a key component of the canonical Wnt signaling
pathway, acts as a coactivator of T cell factor/lymphoid enhancer
factor (TCF/LEF) transcription factors in the nucleus. In epithelial
cells with insuﬃcient Wnt stimulation, β-catenin mainly interacts
with E-cadherin to form adherens junctions and free cytoplasmic
β-catenin is bound by the Axin/APC/GSK3β complex, collectively
termed the “destruction complex”. Next, GSK3β kinase phosphory-
lates the N-terminus of β-catenin at the Ser33/37/Thr41 residues
and targets it for degradation via the ubiquitin-proteasome system.
Previous reports have indicated that (i) CagA interacts with
E-cadherin and disrupts E-cadherin/β-catenin complex formation,
releasing β-catenin from the E-cadherin/β-catenin compelx into the
cytoplasm; and (ii) CagA binds to GSK-3β directly and depletes its
activity, inhibiting the phosphorylation and proteasomal degrada-
tion of cytoplasmic β-catenin [11,12]. As a result, CagA-positive
H. pylori induces the cytoplasmic and nuclear accumulation of
β-catenin. Nuclear accumulation of β-catenin activates theWnt sig-
naling pathway and increases the transcriptional activity of its target
genes, such as c-myc and cyclin D1. This activation has been re-
ported to be regulated by the Akt- and/or PKA-dependent
phosphorylation of β-catenin at Ser552 and Ser675 in the C-terminus.
This phosphorylation increases β-catenin nuclear accumulation and
enhances the recruitment of coactivators, such as TCF4 and 14-3-
3ζ, to promote the transcriptional activity of target genes [18–20].
Nanog and Oct4 (octamer-binding transcription factor 4, also
known as POU class 5 homeobox 1, or POU5F1), which are down-
stream target genes of the Wnt/β-catenin signaling pathway, are
required for the maintenance of self-renewal and pluripotency of
CSCs [21–23]. Additionally, Nanog and Oct4 have been identiﬁed
as two of four factors essential for the reprogramming of somatic
cells into induced pluripotent stem (iPS) cells [24]. Some studies
have suggested that the expression of Nanog and Oct4 is in-
creased during the dedifferentiation process of cancer cells and the
oncogenic transformation of somatic cells [25,26]. Thus, Nanog and
Oct4 play functional roles and are overexpressed in CSCs, and their
upregulation in tumor tissues is correlated with the poor progno-
sis of patients with lung and oral cancers [27,28].
In this study, we found that H. pylori promotes CSC-like prop-
erties in gastric cancer cells via theWnt/β-catenin signaling pathway
in a CagA-dependent manner. Although some studies have con-
ﬁrmed that CagA-positive H. pylori has the ability to activate the
Wnt/β-catenin signaling pathway, the underlying molecular mech-
anism has not been completely elucidated.We further demonstrated
that the increased nuclear accumulation and transcriptional activ-
ity of β-catenin may be dependent on the CagA-positive H. pylori-
mediated C-terminal phosphorylation of β-catenin. Additionally, we
found that H. pylori regulates Nanog and Oct4 via the Wnt/β-
catenin signaling pathway. Human gastric cancer samples from
individuals infected with CagA-positive H. pylori exhibited in-
creased expression of Nanog and Oct4 compared with those from
individuals infected with CagA-negative H. pylori alone.
Materials and methods
Ethical statement and human blood/tissue samples
All experimental procedures were approved by the ethical committee of the Third
Military Medical University. Written informed consent was obtained for all patient
samples. All paired blood and gastric cancer tissues were collected from 29 pa-
tients with gastric cancer at Xinqiao Hospital (during 2014 and 2015). Gastric cancer
diagnosis was made based on HE staining and immunophenotyping results.
Serological analysis and immunohistochemistry
All blood samples were sent to the laboratory for serum preparation, and all serum
samples were detected immediately using a Typing Detection Kit for an antibody
to H. pylori CagA (Catalog no.: CP04, Blot Biotechnology, Shenzhen, China) accord-
ing to the manufacturer’s protocol.
Standard ABC peroxidase techniques were used for immunohistochemistry (IHC).
First, slides were incubated with an anti-Nanog (1:100 dilution, ab62734, Abcam,
USA) or anti-Oct4 antibody (1:100 dilution, ab184665, Abcam, USA). Second, the
primary antibody was detected using a biotinylated secondary antibody (Maxim-
Bio, Fuzhou, China) and an avidin-biotin complex (Maxim-Bio), and the slides were
then stained with DAB (Maxim-Bio). Finally, the slides were counterstained with
Mayer’s hematoxylin. We quantitatively scored tissue sections using ImagePro Plus
(Media Cybernetics, USA).
Cell culture
The human gastric cancer cell line MKN45 was purchased from the Type Culture
Collection of the Chinese Academy of Sciences, and the AGS cell line was pur-
chased from the American Type Culture Collection (ATCC). MKN45 and AGS cells
were cultured in RPMI 1640medium (Catalog no.: C11875500BT, Gibco, USA) supple-
mented with 10% fetal bovine serum (Catalog no.: 10099141, Gibco, USA) in a
humidiﬁed incubator containing 5% CO2 at 37 °C.
H. pylori strains and infection model
The CagA-positive H. pylori strain 11637 (obtained from ATCC) and △CagA (an
isogenic mutant of 11637 lacking CagA, kindly provided by Chihiro Sasakawa) were
grown on brain-heart infusion plates containing 10% rabbit blood at 37 °C under mi-
croaerophilic conditions (5% O2, 10% CO2, and 85% N2). H. pylori was washed from
the culture plates with sterile phosphate-buffered saline (PBS) and then, centri-
fuged at 2500 × g for 5 min, and resuspended in RPMI 1640 medium without
antibiotics. The amount of bacteria was determined by measuring optical density
at 600 nm (1 OD600 = 1 × 109 CFU/ml). RPMI 1640 medium alone served as a blank
control.
Cultured cells were seeded on plates and grown to 80% conﬂuency. Then, H. pylori
was added to cells at a bacteria-to-cell ratio of 100:1 (multiplicity of infection,
MOI = 100).
Flow cytometry analysis
Cells were washed once with PBS, and they were then dissociated from the plates
using Trypsin-EDTA (Catalog no.: T4049, Sigma, USA) and centrifuged. Cell pellets
were resuspended and stained with anti-CD44-FITC (Clone G44-26; BD Pharmingen,
USA), anti-CD24-PE antibodies (Clone ML5; BD Pharmingen, USA), anti-Lgr5-PE an-
tibodies (Clone 8F2; BD Pharmingen, USA) and anti-CD133-PE antibodies (Clone
AC133;Miltenyi Biotec, GER) in a solution containing PBS, 0.5% bovine serum albumin,
2 mmol/L EDTA for 30 min at 4 °C. Finally, the samples were analyzed by ﬂow
cytometry (BD FACSAria II, CA).
Spheroid formation assay
For spheroid formation assay, cells were recovered and 1000 cells were seeded
on non-adherent 24-well culture plates (Costar, Catalog no.: 3473; Corning Inc.,
Corning, NY) in stem cell medium, i.e. serum free DMEM/F12 medium (Catalog no.:
C11320500BT, Gibco, USA) containing 40 ng/ml epidermal growth factor (EGF, Catalog
no.: AF10015, PeproTech Inc., Rocky Hill, NJ), 20 ng/ml basic ﬁbroblast growth factor
(basic-FGF, Catalog no.: 10018B, PeproTech Inc., Rocky Hill, NJ) and B27 supple-
ment (1X, Catalog no.: 17504044, Gibco, USA). After 3 days, an equal amount of fresh
medium was added. Cells were then incubated for 7 days, and spheroids with a di-
ameter of >75 μm were counted under a light microscope.
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Quantitative real-time PCR
Total RNA was extracted using a TRIZOL Reagent Kit (Catalog no.: 15596026,
Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. cDNA was
synthesized from 1 μg of the RNA using random primer according to the manufa-
cturer’s protocol of a PrimeScript RT Reagent Kit (Catalog no.: RR047A, TaKaRa, Ohtsu,
Japan), and quantitative real-time PCR was performed using SYBR GreenMix (Catalog
no.: RR820A, TaKaRa). The detail of reverse transcription and PCR procedures was
provided in Supplementary Materials and Methods. The primers used were syn-
thesized by Sangon Biotech (Shanghai, China) and are listed in Table 1. The results
were normalized to the level of β-actin. Each reaction was performed in triplicate.
Western blotting
After cells were lysed, protein concentrations were measured using a BCA Protein
Assay Kit (Catalog no.: 23250, Thermo, USA) and western blotting analyses were per-
formed as previously described [29]. Primary anti-Nanog (ab184609), anti-Oct4
(ab184665), anti-c-myc (ab39688), anti-Sox2 (ab184529), anti-Klf4 antibodies
(ab155808) were purchased from Abcam (Cambridge, MA, USA); anti-β-catenin
(#8480), anti-p-β-catenin (Ser675) (#4176), anti-p-β-catenin (Ser552) (#5651), anti-
E-cadherin (#3195), anti-N-cadherin (#13116), anti-vimentin antibodies (#5741)
were purchased from Cell Signal Technology (CST, USA); and anti-CagA (sc-28368),
anti-snail (sc-28199), anti-GAPDH (sc-25778), anti-tubulin (sc-58886) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). HRP-conjugated
secondary goat-rabbit (#ZB-2305) and goat-mouse (#ZB-2301) IgG antibodies were
purchased from Zhong Shan Gold Bridge Biotechnology (Beijing, China). An ECL che-
miluminescence kit was purchased from Thermo (Catalog no.: 34095, USA).
Immunoﬂuorescence
Cells were seeded on coverslips and grown to 80% conﬂuency, and they were
then infected with H. pylori for 24 h. Next, the cells were washed once with PBS,
and then ﬁxed in 4% paraformaldehyde for 10 min at room temperature and solu-
bilized in PBS-0.5% Triton-X100 for 15min at room temperature. The cells were then
incubated with 5%BSA for 30 min at room temperature. Next, they were incubated
with primary anti-β-catenin antibody (#8480, CST, USA) overnight at 4 °C and sub-
sequently with the secondary antibodies Alexa Fluor 647 goat-anti mouse IgG and
Cy3-conjugated goat anti-rabbit IgG (each at a 1:100 dilution) for 1 h. DAPI was used
to stain cell nuclei.
Reagents and Luciferase reporter vectors
The following reagents were used: Wnt/β-catenin inhibitor, xav939 (sc-
296704, Santa Cruz, CA, USA), c-met kinase inhibitor, SU11274 (sc-204801, Santa
Cruz, CA, USA), PI3K/Akt inhibitor, and GSK 690693 (sc-363280, Santa Cruz, CA, USA).
Top-Flash (catalog no. 21–170, 5.5 kb) and Fop-Flash (catalog no. 21–169, 5.5 kb.)
were purchased fromMillipore. Construction of luciferase reporter vectors was per-
formed as previously described [29]. Brieﬂy, the promoters of Nanog and Oct4 were
ampliﬁed from human cDNA. The ampliﬁed wild-type Nanog fragment was cloned
into the KpnI and BglII sites of a PGL3-basic vector (Catalog no.: E1751, Promega,
USA), and the ampliﬁed wild-type Oct4 fragment was cloned into the KpnI and XhoI
sites of the PGL3-basic vector. The detail of reaction conditions and the result of iden-
tiﬁcation were provided in Supplementary materials and methods.
Transfection and dual-luciferase assay
Cells were starved for 1 h and were then transfected with luciferase reporter
vectors. Lipofectamine 2000 (Catalog no.: 11668-019, Invitrogen, Carlsbad, CA, USA)
was used to transfect MKN45 cells and X-tremeGENE HP DNA Transfection Reagent
(Catalog no.: 06366546001, Roche, Switzerland) was used to transfect AGS cells.
Cells were seeded in 96-well plates, and cells at approximately 80% conﬂuence
were transfected with the constructed luciferase reporter vectors for 4 h. Transfec-
tion mixtures were then replaced with complete medium. Next H. pylori was added
to the cells at a bacteria-to-cell ratio of 100:1. After 24 h, the cells were harvested
in 1X Reporter Lysis Buffer (Catalog no.: E1960, Promega). Luciferase activity was
determined as the average of three independent assays using a dual-luciferase assay
system (Catalog no.: E1960, Promega). Luciferase activity was normalized to Renilla
luciferase activity.
Chromatin immunoprecipitation (ChIP) assays
ChIP assay was performed following the manufacturer’s instructions (Millipore)
as previously described [29]. Brieﬂy, chromatin was isolated from MKN45 cells in-
fected with H. pylori or treated with xav939 for 24 h. The cells were then ﬁxed for
10 min with 1% formaldehyde and disrupted in EZ-Zyme™ lysis buffer. Lysates were
snap frozen in liquid N2 and then thawed in 37 °C water to cleave chromatin. One
part of chromatin was stored as a positive control for subsequent experiments (“Input”
team), and another party of chromatin was immunoprecipitated with 2 μg IgG as a
negative control (“IgG” team). The rest of chromatin was immunoprecipitated with
an antibody (2 μg) directed against β-catenin. The ﬁnal DNA extracts were PCR
ampliﬁed.
Statistical analysis
Quantitative data are presented as the mean ± standard deviation (SD). Statis-
tical analyses were performed using GraphPad Prism 6.0 software (San Diego, CA,
USA). Unpaired Student’s t test was used to compare two groups, and one-way ANOVA
was used to compare three or more groups. P < 0.05 was considered statistically
signiﬁcant.
Results
CagA-positive H. pylori-infected gastric cancer cells exhibit cancer
stem cell-like properties
CSCs express speciﬁc surface markers and possess the capacity
for self-renewal. Thus, surface markers are widely used to identify
CSCs, and the spheroid formation assay is frequently performed to
assess the capacity of CSCs for self-renewal [17,30]. To examine
whether CagA-positive H. pylori-infected gastric cancer cells exhibit
CSC-like properties, we ﬁrst infected gastric cancer cells with bac-
terial strain 11637 (CagA-positive H. pylori) or an isogenic mutant
of 11637 lacking CagA (11637 △CagA). The number of CD44-
positive gastric cancer cells was signiﬁcantly increased after 11637
wild-type (WT) strain infection, while it was slightly but not sig-
niﬁcantly increased after 11637 △CagA strain infection (Fig. 1A).
Leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5),
initially considered as gastric and intestinal stem cell marker and
gradually regarded as CSC marker in cancer models [31–33], was
also evaluated and showed signiﬁcant increase in 11637WT strain-
infected gastric cancer cells but not in uninfected and 11637△CagA
strain-infected gastric cancer cells (Supplementary Fig. S1A).
However, CD24 and CD133, another CSC markers in gastrointesti-
nal cancer [34,35], was also evaluated but showed no signiﬁcant
change in gastric cancer cells in response toH. pylori infection (Fig. 1A
and Supplementary Fig. S1B). The result of CD24 is in agreement
with those of Bessede et al. who reported that CD24 expression level
was not affected by H. pylori infection in AGS cells [36]. Further-
more, our results indicated that CD133 expression was too low (less
than 1%) in gastric cancer cells, which is consistent with the report
of Zhang et al. in the same cell lines [35]. Recently, Su et al. re-
ported CD133 contributes to maintenance of CSC properties in cell
lines from brain, colon and lung cancers, but not gastric or breast
cancers [37].
Then we performed qRT-PCR to detect the mRNA expression of
CD44 and Lgr5 in H. pylori-infected gastric cancer cells. Consistent
with membrane-expressed CD44 and Lgr5, the mRNA level of CD44
and Lgr5 was signiﬁcantly increased after 11637 WT strain infec-
tion but not after 11637 △CagA strain infection (Fig. 1B and
Supplementary Fig. S1C). Next, spheroid formation assay was per-
formed in vitro under non-adherent culture conditions. After
Table 1
Primer sequences used for real-time PCR.
Gene Sequence
CD44 F: TGCCGCTTTGCAGGTGTAT
R: GGCCTCCGTCCGAGAGA
CD24 F: GACATGGGCAGAGCAATGGTGGC
R: GAGTGAGACCACGAAGAGACTGGC
Lgr5 F: TATGCCTTTGGAAACCTCTC
R: CACCATTCAGAGTCAGTGTT
Nanog F: ACCTATGCCTGTGATTTGTGG
R: AGTGGGTTGTTTGCCTTTGG
Oct4 F: TCAGCTTCCTCCACCCACTT
R: TATTCAGCCAAACGACCATCT
actin F: ACAGAGCCTCGCCTTTGC
R: GCGGCGATATCATCATCC
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infection with the 11637 WT or 11637 △CagA strain for 24 hours,
gastric cancer cells were cultured in serum-free medium under
non-adherent conditions. Gastric cancer cells infectedwith the11637
WT strain showed a signiﬁcantly increased spheroid formation com-
pared with uninfected control cells or 11637 △CagA strain-
infected cells (Fig. 1C). Moreover, the spheroids in gastric cancer
cells infected with the 11637 WT strain were much larger than
those in uninfected control cells or 11637 △CagA strain-infected
cells, as shown in Fig. 1C. Notably, core transcription factors (such
as Nanog, Oct4 and c-myc), which play functional roles and are
overexpressed in CSCs, are being increasingly used as markers for
identifying CSCs [21–23,38]. Therefore, we examined several core
transcription factors, including Nanog, Oct4, c-myc, Sox2 and Klf4,
in both uninfected control gastric cancer cells and in H. pylori (11637
WT or 11637 △CagA strain)-infected gastric cancer cells. Al-
though the expression of Sox2 and Klf4 did not change after H. pylori
infection in gastric cancer cells (Supplementary Fig. S1D), that of
Nanog, Oct4 and c-myc waw signiﬁcantly increased after 11637
WT strain infection but not after 11637 △CagA strain infection
(Fig. 1D). These data indicate that CagA-positive H. pylori-infected
gastric cancer cells exhibit CSC-like properties. However, cells in-
fected with the CagA-mutant strain did not exhibit CSCs-like
properties, indicating that the enhancement of CSCs-like proper-
ties is dependent upon CagA.
Fig. 1. CagA-positive H. pylori-infected gastric cancer cells exhibit cancer stem cell-like properties. After infection with the H. pylori 11637 WT or 11637 △CagA strain for
24 h, MKN45 and AGS cells were harvested. (A) The percentage of CD44-positive cells was quantiﬁed using ﬂow cytometry in H. pylori 11637 WT-infected cells vs uninfected
cells (control) or 11637 △CagA strain-infected cells. (B) The relative expression of CD44 mRNA was measured by PCR. (C) The harvested cells were seeded under non-
adherent culture conditions for spheroid formation. The number of spheroids was quantiﬁed after 7 days. (D) The Nanog, Oct4 and c-myc protein levels were assayed by
western blotting.
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CagA-positive H. pylori activates Wnt/β-catenin signaling, including
β-catenin nuclear accumulation and transcriptional activation
The Wnt/β-catenin signaling pathway, which is closely in-
volved in the regulation of CSCs, has been implicated in
gastrointestinal tumorigenesis via its function in CSCs [15,39]. There-
fore, we hypothesized thatH. pylorimay promote CSC-like properties
in cancer cells via activation of theWnt/β-catenin signaling pathway.
Because previous studies have reported that CagA-positive H. pylori
activates Wnt/β-catenin signaling [11,12,40], we ﬁrst re-evaluated
the capacity of our bacterial strain to promote this signaling pathway.
As expected, infection of gastric cancer cells with the 11637 WT
strain, but not with the 11637 △CagA strain, resulted in nuclear
accumulation of β-catenin (Fig. 2A). Notably, its nuclear accumu-
lation was observed after 11637 WT strain infection, regardless of
whether β-catenin was localized to the cytomembrane in MKN45
cells or to the cytoplasm in AGS cells (Fig. 2A). Next, we per-
formed a luciferase reporter assay to determine the functional
consequences of the CagA-positive H. pylori-induced nuclear trans-
location of β-catenin. This assay revealed that the 11637WT strain
enhanced luciferase activity, while the 11637 △CagA strain did not
(Fig. 2B). These data indicate that the 11637 WT strain induces the
nuclear accumulation and transcriptional activation of β-catenin
and that this process is dependent upon CagA. Although previous
reports have indicated CagA induces the cytoplasmic accumula-
tion of β-catenin by disrupting E-cadherin/β-catenin complex
formation or by depleting GSK-3β activity [11,12], the molecular
mechanisms of β-catenin nuclear accumulation and transcrip-
tional activation have not been completely elucidated during CagA-
positive H. pylori infection.
Fig. 2. CagA-positive H. pylori activates Wnt/β-catenin signaling, including β-catenin nuclear accumulation and transcriptional activation. (A) MKN45 and AGS cells were
infected with H. pylori (11637 WT or 11637 △CagA strain), or pre-treated with an inhibitor of Wnt/β-catenin (XAV, 10 μM) for 1 h, and they were then infected with H. pylori
11637 WT for 24 h. The localization of β-catenin was observed via immunoﬂuorescence. (B) MKN45 and AGS cells were pre-transfected with luciferase reporter constructs
containing LEF/TCF-binding motifs (Top-Flash) or mutated LEF/TCF sites (Fop-Flash) for 4 h. Luciferase activity was measured to assess β-catenin transcriptional activity in
uninfected, 11637 WT-infected, 11637 △CagA strain-infected and XAV pre-treated 11637 WT-infected cells after 24 h. (C) Western blotting was used to assess β-catenin
phosphorylation (Ser675 and Ser552) in MKN45 and AGS cells after H. pylori 11637 WT or 11637 △CagA strain infection for different times. (D) MKN45 and AGS cells were
pre-treated with a c-met inhibitor (SU11274, 5 μM) or a PI3K/Akt inhibitor (GSK, 5 μM) and then infected with H. pylori 11637 WT. Western blotting was performed to
assay β-catenin phosphorylation (Ser675 and Ser552) after the treatment.
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Previous studies have demonstrated that the phosphorylation
of Ser675 and Ser552 in the C-terminus of at β-catenin promotes
its nuclear accumulation and transcriptional activity, resulting in
increased activation of theWnt/β-catenin signaling pathway [18,41].
Therefore, we also evaluated the levels of phosphorylated β-catenin
in uninfected control and H. pylori-infected gastric cancer cells.
Indeed, the 11637WT strain signiﬁcantly promoted the phosphory-
lation of β-catenin at Ser675 and Ser552 in a time-dependent
manner, whereas the 11637△CagA strain did not (Fig. 2C). As phos-
phorylation of β-catenin is well known to be regulated by receptor
tyrosine kinases (RTKs) c-met and its downstream Akt, gastric cancer
cells were treated with c-met the kinase inhibitor SU11274 and the
Akt inhibitor GSK before H. pylori infection. As shown in Fig. 2D, in-
hibition of c-myc and Akt separately induced a signiﬁcant reduction
in the H. pylori-induced phosphorylation of β-catenin at Ser675 and
Ser552 in both MKN45 and AGS cells. These results suggest that
c-myc and Akt are involved in the CagA-positive H. pylori-induced
phosphorylation of β-catenin.
Activation of Wnt/β-catenin signaling is responsible for H.
pylori-induced cancer stem cell-like properties
To investigate whether the activation of Wnt/β-catenin signal-
ing pathway is responsible for H. pylori-induced CSC-like properties,
MKN45 and AGS cells were treated with the Wnt/β-catenin signal-
ing inhibitor XAV before H. pylori infection. Indeed, XAV inhibited
CagA-positive H. pylori-induced nuclear accumulation and the tran-
scriptional activity of β-catenin, indicating that the activation of Wnt/
β-catenin signaling was inhibited (Fig. 2A and B). Next, we performed
ﬂow cytometry analysis to compare the percentages of CD44-
positive gastric cancer cells treatedwith XAV versus those not treated
followed by H. pylori infection. Treatment with XAV resulted in a
reduction in the percentage of 11637 WT strain-induced CD44-
positive gastric cancer cells for both MKN45 and AGS cells (Fig. 3A).
Similarly, the mRNA expression of CD44 in 11637 WT strain-
infected MKN45 and AGS cells was also inhibited by XAV (Fig. 3B).
These results suggest that Wnt/β-catenin signaling has an impor-
tant role in the CagA-positiveH. pylori-induced upregulation of CD44-
positive gastric cancer cells. Next, we investigated the effect of XAV
on CagA-positive H. pylori-induced spheroid formation in MKN45
and AGS cells. As expected, XAV signiﬁcantly inhibited their for-
mation (Fig. 3C). These results suggest that activation of the Wnt/
β-catenin signaling pathway is responsible for H. pylori-induced
cancer stem cell-like properties.
Wnt/β-catenin signaling activation is involved in H. pylori-induced
upregulation of Nanog and Oct4
As shown in Fig. 1D, Nanog and Oct4 expression was upregulated
in CagA-positive H. pylori-infected MKN45 and AGS cells. Thus, to
investigate whether the activation of Wnt/β-catenin signaling could
affect Nanog and Oct4 expression during CagA-positive H. pylori in-
fection, XAV was used to inactivate Wnt/β-catenin signaling. As
shown in Fig. 4A, XAV signiﬁcantly inhibited the upregulation of
Nanog and Oct4 induced by the 11637WT strain in MKN45 and AGS
cells, indicating that the activation of Wnt/β-catenin signaling is in-
volved in the CagA-positive H. pylori-induced upregulation of Nanog
and Oct4. Moreover, the expression of Nanog and Oct4 mRNA was
increased after 11637WT strain infection but not after 11637△CagA
strain infection. The upregulation of Nanog and Oct4 was also in-
hibited by XAV, indicating that H. pylori regulates Nanog and Oct4
at the transcriptional level and that the CagA-positive H. pylori-
induced activation of Wnt/β-catenin signaling is involved in this
process (Fig. 4B). We then constructed two vectors containing either
the promoter of Nanog or the promoter of Oct4. Luciferase report-
er assay revealed that the 11637WT strain enhanced the promoter
activities of Nanog and Oct4, whereas XAV decreased this 11637
WT strain-enhanced promoter activity (Fig. 4C). This ﬁndings in-
dicated that CagA-positive H. pylori may promote the binding of
β-catenin to the promoters of Nanog and Oct4. As revealed in Fig. 4D,
a potential β-catenin-binding site (comprising the sequence:
GTCTGGGT) is present in the Nanog promoter, and two potential
binding sites are present in the Oct4 promoter [22,42]. Subse-
quently, ChIP assay was performed to examine β-catenin binding
sites (BSs). As shown in Fig. 4E, the 11637 WT strain markably
induced β-catenin binding to the BS in the promoter of Nanog,
whereas the 11637 △CagA strain did not, and XAV inhibited this
binding. Meanwhile, the 11637 WT strain only induced β-catenin
binding to BS1 element (sequence: AACAAAG) in the promoter of
Oct4. These results demonstrate that CagA-positive H. pylori pro-
motes Nanog and Oct4 expression through the binding of β-catenin
to their promoters.
CagA-positive H. pylori infection increases Nanog and Oct4
expression in gastric cancer tissues
Considering the ability of CagA-positive H. pylori to upregulate
Nanog and Oct4 expression in vitro in gastric cancer cells, we sought
to determine whether CagA-positive H. pylori infection increases
Nanog and Oct4 expression in gastric cancer tissues. First, we per-
formed the 13C urea breath test to investigate whether patients
diagnosed with gastric cancer were infected with H. pylori. The prev-
alence of H. pylori in these patients was 96.55% (28/29), which is
consistent with previous reports. To further distinguish between the
CagA-positive and CagA-negative patients, we collected blood
samples from these patients for detection of anti-CagA antibody (28
cases, Supplementary Fig. S3A). Eighteen were found to be in-
fectedwith CagA-positiveH. pylori, and the remaining tenwere found
to be infected with CagA-negativeH. pylori. Then, we performed qRT-
PCR and immunohistochemistry to examine the relationship between
H. pylori infection and Nanog and Oct4 expression in the tissues of
the gastric cancer patients. As shown in Fig. 5A, 5B and Table 2, sig-
niﬁcantly increased expression of Nanog and Oct4 protein was
detected in the gastric cancer samples in association with CagA-
positive H. pylori infection compared with CagA-negative infection.
Moreover, the relative mRNA expression of Nanog and Oct4 were
also increased in gastric cancer tissues from CagA-positive H. pylori-
infected patients compared with CagA-negative H. pylori-infected
patients (Fig. 5C).
Discussion
In this study, we have shown that CagA-positive H. pylori-
infected gastric cancer cells exhibit CSC-like properties. Previous
studies have suggested that the epithelial-mesenchymal transi-
tion (EMT) is a developmental process during which epithelial cells
acquire stem cell-like properties [43]. Recent evidence suggests that
H. pylori infection induces the EMT, which may play a potential role
in the emergence of gastric CSCs [36,44]. Thus, we evaluated the
capacity of our bacterial strain to induce the EMT. Infection with
the 11637 WT strain resulted in the emergence of EMT-like phe-
notype, whereas this phenotypewas not observedwith 11637△CagA
strain (Supplementary Fig. S2A). Decreased expression of the epi-
thelial marker E-cadherin, along with increased expression of the
mesenchymal markers N-cadherin, Vimentin and Snail, were also
observed in 11637 WT strain-infected gastric cancer cells
(Supplementary Fig. S2B). These ﬁndings indicate that the en-
hanced CSC-like properties are coincident with the EMT phenotype
following CagA-positive H. pylori infection. However, this evi-
dence is still insuﬃcient to conﬁrm that CagA-positive H. pylori-
infected gastric cancer cells exhibit CSC-like properties via the EMT,
as there is no direct evidence that suppression of the EMT inhibits
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CagA-positive H. pylori-induced CSC-like properties in these cells.
In addition, H. pylori may promote the self-renewal of a handful of
CSCs to exhibit CSC-like properties in gastric cancer cells. A recent
study has reported thatH. pylori has the ability to activate and expand
gastric stem cells through direct colonization in themiddle of gastric
glands, where an abundance of these gastric stem cells are present
[45]. Although CagA is not required for gland colonization, it con-
tributes to accelerated proliferation of gastric stem cells [45]. These
results imply that CagA-positiveH. pylorimay enhance CSC-like prop-
erties via EMT-like changes or the acceleration of CSC self-renewal.
The mechanism of the H. pylori-induced EMT has been clariﬁed as
follows: (i) H. pylori induces the EMT in gastric cancer cells, par-
tially mediated by a cooperative network involving H. pylori-
induced MMP-7, HB-EGF and gastrin upregulation [46]; (ii) H. pylori
secretes large amounts of tumor necrosis factor-α-inducing protein
(Tipα), which induces the EMT by directly binding to nucleolin on
the cell surface to promote the expression of TNF-α and activation
of NF-κB [47]; (iii) H. pylori CagA induces the snail-mediated EMT
via the depletion of GSK-3β [12]; (iv) H. pylori CagA induces the
twist1-mediated EMT via the inhibition of programmed cell death
factor 4 [48]. However, the mechanism of H. pylori-induced CSC self-
renewal has not been clariﬁed.
Wnt/β-catenin signaling plays an essential role in the mainte-
nance of CSC properties, including self-renewal and speciﬁc marker
expression. Activation of Wnt/β-catenin signaling accelerates the
self-renewal of CSCs and upregulates the expression of CSCmarkers,
Fig. 3. The activation of Wnt/β-catenin signaling is responsible for H. pylori-induced cancer stem cell-like properties. MKN45 and AGS cells were infected with H. pylori
(11637 WT or 11637 △CagA strain), or pre-treated with an inhibitor of Wnt/β-catenin (XAV, 10 μM) for 1 h, and they were then infected with H. pylori 11637 WT for 24 h.
(A) The percentage of CD44-positive cells was quantiﬁed by ﬂow cytometry. (B) The relative expression of CD44 mRNA was measured by PCR. (C) Uninfected cells, H. pylori-
infected cells or XAV pre-treated H. pylori-infected cells were seeded under non-adherent culture conditions for spheroid formation. The number of spheroids was quantiﬁed
after 7 days.
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Fig. 4. Wnt/β-catenin signaling activation is involved in the H. pylori-induced upregulation of Nanog and Oct4. Nanog and Oct4 expression were assayed by western blot-
ting (A) and PCR (B) in uninfected, 11637 WT-infected, 11637 △CagA strain-infected or XAV pre-treated 11637 WT-infected MKN45 and AGS cells. (C) MKN45 and AGS
cells were pre-transfected with luciferase reporter constructs containing the Nanog promoter or the Oct4 promoter for 4 h. Luciferase activity was measured to assess pro-
moter activity in uninfected, 11637 WT-infected, 11637 △CagA strain-infected and XAV pre-treated 11637 WT-infected cells after 24 h. (D) The potential binding sites for
β-catenin in the promoters of Nanog and Oct4. (E) ChIP assays were performed using chromatin isolated from in uninfected, 11637 WT-infected, 11637 △CagA strain-
infected or XAV pre-treated 11637 WT-infected MKN45 cells. Final DNA extracts were PCR-ampliﬁed using primers that covered the potential binding sites in the Nanog
and Oct4 promoter regions. “IgG” team means negative control, and “Input” team means positive control.
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whereas blockade of this signaling suppresses CSC properties [49,50].
In the tumor metabolic microenvironment, chronic metabolic stress
could cause cancer cells to exhibit CSC-like properties via activa-
tion of Wnt/β-catenin [51]. In this study, we found that CagA-
positive H. pylori was able to activate the Wnt/β-catenin signaling
pathway. The nuclear accumulation and transcriptional activity of
β-catenin are increased during CagA-positive H. pylori infection
(Fig. 2A and B). Blockade ofWnt/β-catenin signaling suppresses CagA-
positive H. pylori-induced CSC-likes properties (Fig. 3). Therefore,
activation of the Wnt/β-catenin signaling pathway is responsible
for the emergence of H. pylori-induced CSC-like properties.
Phosphorylation of β-catenin affects its stabilization, localiza-
tion and function. It is well known that β-catenin protein stability
is controlled by the GSK3β-mediated phosphorylation of β-catenin
at Ser33/37/Thr41 and subsequent its proteasomal degradation,
whereas the GSK3β-mediated phosphorylation of β-catenin at Ser552
results in its nuclear accumulation and transcriptional activation [18].
Additionally, the RTK-mediated phosphorylation of β-catenin at
Tyr654 results in its release from cadherin and an increase in its
PKA-mediated phosphorylation of at Ser675. Thus, enhanced Tyr654
and Ser675 phosphorylation of β-catenin has been suggested to in-
crease its nuclear accumulation and transcriptional activation [41].
In this study, we found that CagA-positive H. pylori promoted the
phosphorylation of β-catenin at Ser552 and Ser675 in a time-
dependent manner (Fig. 2C). These results could partly explain the
H. pylori-induced nuclear accumulation and transcriptional activa-
tion of β-catenin. Furthermore, the phosphorylation of β-catenin
at Ser552 and Ser675 is correlated with c-met and its down-
streammolecule Akt. Previous studies have indicated that H. pylori
CagA is involved in the interaction with c-met and the activation
of Akt [13,52]. Therefore, we used SU11274 and GSK to inhibit the
activation of c-met and Akt separately. As shown in Fig. 2D, the
Fig. 5. CagA-positive H. pylori infection increases Nanog and Oct4 expression in gastric cancer tissues. (A) Representative immunohistochemical staining for Nanog and Oct4
in gastric cancer tissues from CagA-positive H. pylori-infected and CagA-negative H. pylori-infected patients. (B) The relative Nanog and Oct4 staining intensity in gastric
cancer tissues from CagA-positive H. pylori-infected (n = 18) and CagA-negative H. pylori-infected patients (n = 10). The detail of statistics results were showed in Table 2.
(C) The relative mRNA expression of Nanog and Oct4 in gastric cancer tissues from CagA-positive H. pylori-infected and CagA-negative H. pylori-infected patients.
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CagA-positive H. pylori-induced phosphorylation of β-catenin at
Ser552 and Ser675 was signiﬁcantly inhibited by treatment with
SU11274 or GSK. Thus, CagA-positive H. pylori induces the phos-
phorylation of β-catenin at Ser552 and Ser675 in a c-met- and/or
Akt-dependent manner, resulting in β-catenin nuclear accumula-
tion and transcriptional activation.
Nanog and Oct4 are downstream target genes of Wnt/β-catenin
signaling, and those proteins have been suggested to be critical regu-
lators of CSC self-renewal and pluripotency [38,53]. Moreover, Nanog
and Oct4 have also been implicated in promoting the EMT [27,54].
Consistent with these ﬁndings, the elevated expression of Nanog
and Oct4 has been associated with the late-stage progression and
poor prognosis of patients with cancer [27,28,38]. In this study, we
found that CagA-positive H. pylori upregulated Nanog and Oct4
through activation of Wnt/β-catenin signaling (Fig. 4A and B). To
further conﬁrm the role of β-catenin in the H. pylori-induced
upregulation of Nanog and Oct4, we performed luciferase report-
er and ChIP assays to conﬁrm that β-catenin binds to the
−137 ~ −130 bp region of the Nanog promoter and to the
−236 ~ −230 bp/−1642 ~ −1632 bp regions of the Oct4 promoter
(Fig. 4C and D). In addition, the clinical data revealed that Nanog
and Oct4 were signiﬁcantly increased in the gastric cancer samples
from CagA-positive H. pylori-infected patients compared with those
from the CagA-negative H. pylori-infected patients (Fig. 5B and C).
To our knowledge, this study is the ﬁrst to demonstrate that CagA-
positive H. pylori activates Wnt/β-catenin signaling to inﬂuence the
expression of Nanog and Oct4 in gastric cancer cells.
In summary, the mechanism of H. pylori-induced CSC-like prop-
erties should was examined in this study. As previously described,
the H. pylori-induced EMTmay partly, but not fully, explain this phe-
notype. Therefore, further exploration of themechanism of H. pylori-
induced CSC-like properties is needed. Nanog and Oct4 have the
ability to induce CSC-like properties and enhance the EMT, con-
tributing to tumorigenesis [27,38,53,54]. In this study, we
demonstrated that CagA-positive H. pylori regulates Nanog and Oct4
viaWnt/β-catenin signaling, which promotes the emergence of CSC-
like properties in gastric cancer cells. Moreover, we found that CagA-
positive H. pylori promotes the phosphorylation of β-catenin at
Ser675 and Ser552 in a c-met- and/or Akt-dependent manner, which
may partly elucidate themechanisms of theH. pylori-induced nuclear
accumulation and transcriptional activation of β-catenin. Based on
previous reports and our observations, we propose the following
model (Fig. 6). First, once CagA is injected into gastric cancer cells
via the T4SS during H. pylori infection, it directly binds to GSK-3β
and depletes its activity, inhibiting β-catenin degradation [12]. Mean-
while, CagA interacts with E-cadherin and disrupts E-cadherin/β-
catenin complex formation, releasing in the release of β-catenin from
E-cadherin and the unfolding of the protein for Ser675 phosphory-
lation at the β-catenin C-terminus [11,41]. Then, CagA interacts with
c-met and activates the downstreammolecule Akt, resulting in phos-
phorylation of β-catenin at Ser675 and Ser552. Next, this
phosphorylation increases nuclear accumulation and transcrip-
Table 2
The detail of statistics results of Nanog and Oct4 expression in gastric cancer tissues.
CagA+ H. pylori Nanog Oct4 CagA− H. pylori Nanog Oct4
Sample 1 0.58311 0.61733 Sample 1 0.50059 0.44737
Sample 2 0.55272 0.60912 Sample 2 0.46410 0.42163
Sample 3 0.60307 0.65166 Sample 3 0.45629 0.40370
Sample 4 0.57332 0.53900 Sample 4 0.42897 0.52391
Sample 5 0.56091 0.54674 Sample 5 0.48063 0.53887
Sample 6 0.48937 0.57061 Sample 6 0.45311 0.51433
Sample 7 0.52096 0.50877 Sample 7 0.49688 0.48553
Sample 8 0.65491 0.42399 Sample 8 0.52119 0.43989
Sample 9 0.45387 0.48984 Sample 9 0.54322 0.45119
Sample 10 0.56192 0.49118 Sample 10 0.46980 0.44706
Sample 11 0.52007 0.50397
Sample 12 0.58674 0.52099
Sample 13 0.48680 0.56431
Sample 14 0.51877 0.51090
Sample 15 0.54989 0.46355
Sample 16 0.53062 0.47001
Sample 17 0.43842 0.49213
Sample 18 0.57099 0.48766
Fig. 6. Model of the H. pylori-mediated regulation of Nanog and Oct4 via the Wnt/β-catenin signaling pathway, which promotes cancer stem cell-like properties in human
gastric cancer.
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tional activity of β-catenin, resulting in increased Wnt/β-catenin
signaling. This activation upregulates Nanog and Oct4 expression
and promotes the emergence of CSC-like properties in gastric cancer
cells.
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